These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37571864)

  • 21. Treating port wine stain birthmarks by using dynamic optical coherence tomography-guided settings.
    Christman MP; Feng H; Holmes J; Geronemus RG
    J Am Acad Dermatol; 2023 Jan; 88(1):e11-e13. PubMed ID: 31437547
    [No Abstract]   [Full Text] [Related]  

  • 22. Current clinical evidence is insufficient to support HMME-PDT as the first choice of treatment for young children with port wine birthmarks.
    Gao C; Nguyen V; Hochman ML; Gao L; Chen EH; Friedman HI; Nelson JS; Tan W
    Lasers Surg Med; 2024 Apr; 56(4):321-333. PubMed ID: 38506454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anesthetic techniques used for pulsed dye laser (PDL) in the treatment of port-wine birthmarks: An exploratory assessment of current attitudes and practice patterns among pediatric dermatologists in the United States.
    Klein A; Aggarwal P; Mannschreck D; Cohen BA
    Pediatr Dermatol; 2021 May; 38(3):575-579. PubMed ID: 33611836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsed dye laser double-pass treatment of patients with resistant capillary malformations.
    Rajaratnam R; Laughlin SA; Dudley D
    Lasers Med Sci; 2011 Jul; 26(4):487-92. PubMed ID: 21476044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Port-wine stain laser treatments and novel approaches.
    Ortiz AE; Nelson JS
    Facial Plast Surg; 2012 Dec; 28(6):611-20. PubMed ID: 23188689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Topical Sirolimus for Pulsed Dye Laser in Pediatric Capillary Malformation.
    Gu Y; Sebaratnam DF
    Dermatol Surg; 2024 Mar; 50(3):300-301. PubMed ID: 38051197
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment.
    Jia W; Sun V; Tran N; Choi B; Liu SW; Mihm MC; Phung TL; Nelson JS
    Lasers Surg Med; 2010 Feb; 42(2):105-12. PubMed ID: 20166161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks.
    Phung TL; Oble DA; Jia W; Benjamin LE; Mihm MC; Nelson JS
    Lasers Surg Med; 2008 Jan; 40(1):1-5. PubMed ID: 18220264
    [No Abstract]   [Full Text] [Related]  

  • 29. 532-nm potassium titanyl-phosphate laser versus 595-nm pulsed dye laser for port-wine birthmarks: A prospective, randomized, split-side study.
    Nguyen L; Seeber N; Kautz G; Hartjen A; Schneider SW; Herberger K
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1140-1146. PubMed ID: 38794945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of capillary malformations in capillary malformation-arteriovenous malformation syndrome with pulsed dye laser.
    Ang YS; Koh MJA
    J Cosmet Dermatol; 2021 Nov; 20(11):3710-3711. PubMed ID: 33655684
    [No Abstract]   [Full Text] [Related]  

  • 31. Largest comparative analysis: Novel large spot size 595 nm, high-energy, pulsed dye laser reduces number of treatments for improvement of adult and pediatric port wine birthmarks.
    Sodha P; Wang JV; Aboul-Fettouh N; Martin K; Geronemus RG; Friedman PM
    Lasers Surg Med; 2023 Oct; 55(8):741-747. PubMed ID: 37293831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of port wine stains with pulsed dye laser in patients with systemic lupus erythematosus: practical considerations and complications.
    Izikson L; Avram M; Tannous Z
    J Cosmet Laser Ther; 2008 Dec; 10(4):223-5. PubMed ID: 18830867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Port-wine stains treated by pulsed-dye laser with sedation: A retrospective observational efficacy and safety in 18 children].
    Fenot M; Maillard H; Célérier P; Maxaud A; Bénéton N
    Ann Dermatol Venereol; 2014; 141(6-7):419-28. PubMed ID: 24951140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of a resistant port-wine stain with a new variable pulse-duration pulsed-dye laser.
    Bernstein EF
    J Cosmet Dermatol; 2008 Jun; 7(2):139-42. PubMed ID: 18482019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of two pediatric port wine stains in darker skin types using 595 nm laser.
    Bae YS; Ng E; Geronemus RG
    Lasers Surg Med; 2016 Apr; 48(4):339-42. PubMed ID: 26749116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of a resistant port-wine stain with the 1.5-msec pulse duration, tunable, pulsed dye laser.
    Bernstein EF
    Dermatol Surg; 2000 Nov; 26(11):1007-9. PubMed ID: 11096384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical metformin suppresses angiogenesis pathways induced by pulsed dye laser irradiation in animal models.
    Wang M; Lin Y; Shi W; Chen X; Mi Z; Jia Z; Pan Q; Wang Z; Han J; Liu H
    Exp Dermatol; 2022 Mar; 31(3):393-397. PubMed ID: 34564891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EMLA cream does not influence efficacy and pain reduction during pulsed-dye laser treatment of port-wine stain: a prospective side-by-side comparison.
    Yu W; Wang T; Zhu J; Qiu Y; Chen H; Jin Y; Yang X; Hu X; Chang L; Chen Y; Ma G; Lin X
    Lasers Med Sci; 2018 Apr; 33(3):573-579. PubMed ID: 29247433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulsed Dye Laser at Subpurpuric Settings for the Treatment of Pulsed Dye Laser-Induced Ecchymoses in Patients With Port-Wine Stains.
    Brauer JA; Farhadian JA; Bernstein LJ; Bae YS; Geronemus RG
    Dermatol Surg; 2018 Feb; 44(2):220-226. PubMed ID: 28858925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lasers or light sources for treating port-wine stains.
    Faurschou A; Olesen AB; Leonardi-Bee J; Haedersdal M
    Cochrane Database Syst Rev; 2011 Nov; (11):CD007152. PubMed ID: 22071834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.